NCT05733039

Brief Summary

Expectations are a major driver of changes in health-related outcomes and are related to reduced pain after medical treatment. However, no studies have specifically addressed the role of expectations in connection with the success of interventional pain techniques and the specific effect of expectations on diagnostic and therapeutic procedures in this field. Further, there are no studies on prolonged pain reduction after diagnostic nerve blocks. This prospective cohort study will investigate patients' outcome-related expectations measured by validated questionnaires (i.a. the Expectation for Treatment Scale) before standardized diagnostic nerve blocks (i.e. lumbar medial branch and greater occipital nerve blocks) and their association with immediate pain reduction, calculated using a numeric rating scale (NRS) before and after the block. Secondary outcomes are specificity of pain relief duration in relation to the local anesthetic, changes in pain-related interference, quality of life and function, as well as patients' global impression of change after one week in order to assess possible therapeutic effects of the nerve blocks themselves. The sample size of 110 patients is based on a power of 80% and a significance level of 0.05. Additional endpoints will be evaluated using mixed-effects linear regression, non-linear relationships between expectation and endpoints will be modelled using fractional polynomials. This research will quantify the effect of patients' expectations on pain reduction after nerve blocks, extend our knowledge which patients are likely to respond to interventional pain treatments and under which circumstances nerve blocks may exhibit therapeutic effects.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Jun 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Jun 2021Dec 2026

Study Start

First participant enrolled

June 1, 2021

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

February 17, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
2.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

2.7 years

First QC Date

July 14, 2022

Last Update Submit

March 26, 2025

Conditions

Keywords

PainExpectationsLocal anaestheticPain treatment

Outcome Measures

Primary Outcomes (1)

  • Change in pain intensity

    Change in pain intensity directly after the diagnostic nerve block, calculated on an 11-point numeric rating scale (NRS 0-10, 0=no pain; 10=unbearable pain) before and 30 minutes after the nerve block.

    30 minutes

Secondary Outcomes (4)

  • Change in pain intensity (longterm)

    1 week

  • Specificity of local anesthetic

    1 day

  • Pain-related disability after 1 week

    1 week

  • Patient Global Impression of Change (PGIC) after 1 week

    1 week

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All referred pain patients (acute and chronic), scheduled for a first diagnostic nerve block.

You may qualify if:

  • referral to our pain clinic
  • interventions: Lumbar medial branch block or greater occipital nerve block, both with lidocaine 2%

You may not qualify if:

  • Psychiatric co-morbidities other than depression
  • Inability to express pain scores on a numeric rating scale
  • Refusal of informed consent
  • Insufficient knowledge of German, French or English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inselspital, Bern University Hospital

Bern, Canton of Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

PainAgnosia

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • Michael Harnik, Dr. med.

    Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med., senior physician

Study Record Dates

First Submitted

July 14, 2022

First Posted

February 17, 2023

Study Start

June 1, 2021

Primary Completion

February 1, 2024

Study Completion (Estimated)

December 1, 2026

Last Updated

April 1, 2025

Record last verified: 2025-03

Locations